This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Non-follicular lymphoma
DOID EFO MESH SNOMED Endpoint Browser
CD2_NONFOLLICULAR_LYMPHOMA
neoplasm of mature B-cells: A neoplasm of follicle centre B cells which has at least a partial follicular pattern. Follicular lymphomas comprise about 35% of adult non-Hodgkin lymphomas in the U.S. and 22% worldwide. Most patients have widespread disease at diagnosis. Morphologically, follicular lymphomas are classified as Grade 1, Grade 2, and Grade 3, depending on the percentage of the large lymphocytes present. The vast majority of cases (70-95%) express the BCL-2 rearrangement [t(14;18)]. Histological grade correlates with prognosis. Grades 1 and 2 follicular lymphomas are indolent and grade 3 is more aggressive (adapted from WHO, 2001).
Endpoint definition
↥
FinnGen phenotype data
429209 individuals
Apply sex-specific rule None
429209
Check conditions None
429209
Check pre-conditions, main-only, mode, registry filters
Hospital Discharge: ICD-10
C83
Hospital discharge: ICD-9
200
Hospital discharge: excluded ICD-9
200A
Cause of death: ICD-10
C83
Cause of death: ICD-9
200
Cause of death: excluded ICD-9
200A
2 out of 7 registries used, show all original rules.
2907
Check minimum number of events None
2907
Include endpoints None
2907
Remove individuals based on genotype QC
2811
CD2_NONFOLLICULAR_LYMPHOMA
Control definitions
Controls for this endpoint are individuals that are not cases.
Extra metadata
Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF4
Parent code in ICD-10
C81-C96
Name in latin
Lymphoma non-Hodgkin diffusum
Show upset plot detailing case counts by codes
Or the full data table
Similar endpoints
↥List of similar endpoints to
Non-follicular lymphoma
based on the number of shared cases.
Broader endpoints:
- Non-follicular lymphoma (controls excluding all cancers)
- Primary_lymphoid and hematopoietic malignant neoplasms
- Primary_lymphoid and hematopoietic malignant neoplasms (controls excluding all cancers)
- Malignant neoplasm (controls excluding all cancers)
- Malignant neoplasm
Narrower endpoints:
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2811 | 1140 | 1671 |
| Unadjusted prevalence (%) | 0.68 | 0.50 | 0.92 |
| Mean age at first event (years) | 63.42 | 61.45 | 64.76 |
Mortality
Not a core endpoint, no data to show.
Age distribution of first events
Year distribution of first events
Cumulative Incidence
Not a core endpoint, no data to show.
Correlations
↥
Index endpoint: CD2_NONFOLLICULAR_LYMPHOMA – Non-follicular lymphoma
GWS hits: 1
Survival analyses between endpoints
↥Not a core endpoint, no data to show.
Drugs most likely to be purchased after Non-follicular lymphoma
↥Endpoint not on priority list, no data to show.